LifePlan Financial Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$0 Hold
1
﹤0.01% 572
2020
Q2
$0 Hold
1
﹤0.01% 570
2020
Q1
$0 Hold
1
﹤0.01% 550
2019
Q4
$0 Hold
1
﹤0.01% 552
2019
Q3
$0 Hold
1
﹤0.01% 547
2019
Q2
$0 Hold
1
﹤0.01% 544
2019
Q1
$0 Hold
1
﹤0.01% 546
2018
Q4
$0 Hold
1
﹤0.01% 541
2018
Q3
$0 Hold
1
﹤0.01% 536
2018
Q2
$0 Hold
1
﹤0.01% 521
2018
Q1
$0 Buy
+1
New +$47 ﹤0.01% 513

Other funds holding AVNS

LifePlan Financial Group's AVNS Position: Q3 2020 in Review

LifePlan Financial Group held its Avanos Medical (AVNS) position steady in Q3 2020 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #572.

LifePlan Financial Group first reported a position in AVNS in Q1 2018 and has held it in 11 quarters since. 272 funds tracked by Wall St. Rank hold AVNS as of Q3 2020.

  • LifePlan Financial Group held 1 share of Avanos Medical worth $0 as of Q3 2020.
  • LifePlan Financial Group left its Avanos Medical share count unchanged in Q3 2020.
  • Avanos Medical made up ﹤0.01% of LifePlan Financial Group's portfolio in Q3 2020, its #572 holding.
  • LifePlan Financial Group first reported a position in Avanos Medical in Q1 2018 and has held it in 11 quarters since.
  • 272 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2020.

Based on LifePlan Financial Group's 13F filing for Q3 2020, filed 30 Oct 2020.